Velocity Clinical Research, Norfolk — Norfolk, Nebraska

Velocity Clinical Research, Norfolk is a clinical research site located in Norfolk, Nebraska, United States 68701.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Norfolk has participated in 15 clinical trials with 4 currently active.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, Meningococcal Vaccine.

Sponsors: BioNTech SE, Pfizer, Currax Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Norfolk?

Velocity Clinical Research, Norfolk has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Norfolk conducted?

Velocity Clinical Research, Norfolk has 15 clinical trials on record, with 4 currently active. Their work covers SARS-CoV-2 Infection, COVID-19, Meningococcal Vaccine.

Is Velocity Clinical Research, Norfolk accredited by Crixeo Health?

Yes — Velocity Clinical Research, Norfolk holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research, Norfolk?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.